Mike Griffiths
Overview
Explore the profile of Mike Griffiths including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gill C, Griffiths M, Easton A, Solomon T
Br J Nurs
. 2022 Jan;
31(1):40-45.
PMID: 35019745
Aim: To explore the experiences of registered nurses providing care to adult patients affected by encephalitis, from admission into hospital through to discharge. Study Design: A qualitative phenomenological methodology was...
2.
Schaffer A, Parikh S, Toma S, Thexton N, Kcomt A, Griffiths M, et al.
Bipolar Disord
. 2021 May;
23(5):528-530.
PMID: 33934453
No abstract available.
3.
Kinsella F, Inman C, Gudger A, Chan Y, Murray D, Zuo J, et al.
Leuk Res
. 2019 Jul;
83:106173.
PMID: 31276965
Background: The importance of chimerism status in the very early period after hematopoietic stem cell transplantation is unclear. We determined PBMC and T-cell donor chimerism 50 days after transplantation and...
4.
Ward D, Gordon N, Boucher R, Pirrie S, Baxter L, Ott S, et al.
BJU Int
. 2019 May;
124(3):532-544.
PMID: 31077629
Objectives: To develop a focused panel of somatic mutations (SMs) present in the majority of urothelial bladder cancers (UBCs), to investigate the diagnostic and prognostic utility of this panel, and...
5.
Kinsella F, Zuo J, Inman C, Pearce H, Maggs L, Eldershaw S, et al.
Blood Adv
. 2019 Mar;
3(5):734-743.
PMID: 30824417
Transplantation is an effective treatment of many clinical disorders, but the mechanisms that regulate immunological tolerance are uncertain and remain central to improving patient outcome. Hemopoietic stem cell transplantation (SCT)...
6.
Lindsay C, Shaw E, Blackhall F, Blyth K, Brenton J, Chaturvedi A, et al.
ESMO Open
. 2018 Sep;
3(6):e000408.
PMID: 30233821
Introduction: Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as...
7.
Quek L, Ferguson P, Metzner M, Ahmed I, Kennedy A, Garnett C, et al.
Blood Adv
. 2018 Jan;
1(3):193-204.
PMID: 29296935
Disease relapse is the major cause of treatment failure after allogeneic stem cell transplantation (allo-SCT) in acute myeloid leukemia (AML). To identify AML-associated genes prognostic of AML relapse post-allo-SCT, we...
8.
Pratt G, Yap C, Oldreive C, Slade D, Bishop R, Griffiths M, et al.
Br J Haematol
. 2017 Jun;
182(3):429-433.
PMID: 28643365
No abstract available.
9.
Davies N, Kwok M, Gould C, Oldreive C, Mao J, Parry H, et al.
Oncotarget
. 2017 May;
8(27):44749-44760.
PMID: 28496009
Subclonal heterogeneity and clonal selection influences disease progression in chronic lymphocytic leukemia (CLL). It is therefore important that therapeutic decisions are made based on an understanding of the CLL clonal...
10.
Parks M, Court S, Bowns B, Cleary S, Clokie S, Hewitt J, et al.
Eur J Hum Genet
. 2017 Jan;
25(4):416-422.
PMID: 28120840
Although technically possible, few clinical laboratories across the world have implemented non-invasive prenatal diagnosis (NIPD) for selected single-gene disorders, mostly owing to the elevated costs incurred. Having previously proven that...